Ralf Schirrmacher

Department of Oncology, University of Alberta

Research Area

Biography

Ralf Schirrmacher has not added Biography.
If you are Ralf Schirrmacher and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2020

Other Publications

Article	Year
¹⁸F-labeled silicon-based fluoride acceptors: potential opportunities for novel positron emitting radiopharmaceuticals. BioMed research international\| PubMed ID: 25157357	2014
5-(4-((4-[(18)F]Fluorobenzyl)oxy)-3-methoxybenzyl)pyrimidine-2,4-diamine: a selective dual inhibitor for potential PET imaging of Trk/CSF-1R. Bioorganic & medicinal chemistry letters\| PubMed ID: 25257201	2014
In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 25977461	2015
Improving the stability of peptidic radiotracers by the introduction of artificial scaffolds: which structure element is most useful? Journal of labelled compounds & radiopharmaceuticals\| PubMed ID: 26219022	2015
Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition. Expert opinion on therapeutic patents\| PubMed ID: 26561352	2016
From Unorthodox to Established: The Current Status of (18)F-Trifluoroborate- and (18)F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging. Bioconjugate chemistry\| PubMed ID: 26566577	2016
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging. Molecules (Basel, Switzerland)\| PubMed ID: 26690113	2015
Radiosynthesis and Preclinical Evaluation of F-Fluoroglycosylated Octreotate for Somatostatin Receptor Imaging. Bioconjugate chemistry\| PubMed ID: 27715017	2016
Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I. Expert opinion on therapeutic patents\| PubMed ID: 28270010	2017
Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II. Expert opinion on therapeutic patents\| PubMed ID: 28270021	2017
Design and synthesis of a fluorinated quinazoline-based type-II Trk inhibitor as a scaffold for PET radiotracer development. Bioorganic & medicinal chemistry letters\| PubMed ID: 28476569	2017
A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human. Journal of medicinal chemistry\| PubMed ID: 28696690	2017
Small Prosthetic Groups in F-Radiochemistry: Useful Auxiliaries for the Design of F-PET Tracers. Seminars in nuclear medicine\| PubMed ID: 28826522	2017
Automated synthesis of PET radiotracers by copper-mediated F-fluorination of organoborons: Importance of the order of addition and competing protodeborylation. Journal of labelled compounds & radiopharmaceuticals\| PubMed ID: 29143408	2018
Synthesis, in vitro and in vivo evaluation of F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors. Nuclear medicine and biology\| PubMed ID: 29175467	2018
F-Radiolabeling and In Vivo Analysis of SiFA-Derivatized Polymeric Core-Shell Nanoparticles. Bioconjugate chemistry\| PubMed ID: 29202229	2018
Identification of [F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging. Journal of medicinal chemistry\| PubMed ID: 29257860	2018
Recent Advances in F Radiochemistry: A Focus on B-F, Si-F, Al-F, and C-F Radiofluorination via Spirocyclic Iodonium Ylides. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 29284673	2018
Gastrin-Releasing Peptide Receptor- and Prostate-Specific Membrane Antigen-Specific Ultrasmall Gold Nanoparticles for Characterization and Diagnosis of Prostate Carcinoma via Fluorescence Im... Bioconjugate chemistry\| PubMed ID: 29542916	2018
Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC-Receptors concomitantly overexpressed on various malignancies - Is the concept ... European journal of medicinal chemistry\| PubMed ID: 29864700	2018
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging? Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 29973529	2018
iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with Ga and Cu: Unexpected Findings. ACS omega\| PubMed ID: 30411057	2018
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 30609832	2019
First-in-Human Brain Imaging of [F]TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS chemical neuroscience\| PubMed ID: 31017386	2019